Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

INTRODCUTION: Through interaction with receptors TNFR1 and TNFR2, TNF-α activates a signal path, which exacerbates an inflammatory process, constituting an inseparable element of psoriasis. AIM: To evaluate changes in the expression of TNF-α, TNFR1, TNFR2 during the 4-year-long adalimumab therapy in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Postepy Dermatol Alergol
Main Authors: Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Kruszniewska-Rajs, Celina, Swinarew, Andrzej, Jasik, Krzysztof, Rozwadowska, Beata, Krawczyk, Agata
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675078/
https://ncbi.nlm.nih.gov/pubmed/33240014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2020.100484
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados